Reversine triggers mitotic catastrophe and apoptosis in K562 cells-Reference-Cited by-同舟云学术

Reversine triggers mitotic catastrophe and apoptosis in K562 cells

Published:2016-09 Issue: Volume:48 Page:26-31
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Rodrigues Alves Ana Paula Nunes,Machado-Neto João Agostinho,Scheucher Priscila Santos,Paiva Helder Henrique,Simões Belinda Pinto,Rego Eduardo Magalhães^ORCID,Traina Fabiola

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference33 articles.

1. Translation of the Philadelphia chromosome into therapy for CML;Druker;Blood,2008

2. Use of second- and third-generation tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia: an evolving treatment paradigm;Jabbour;Clin. Lymphoma Myeloma Leukemia,2015

3. Bcr-Abl activates AURKA and AURKB in chronic myeloid leukemia cells via AKT signaling;Yang;Int. J. Cancer,2014

4. Aurora kinases and potential medical applications of aurora kinase inhibitors: a review;Gavriilidis;J. Clin. Med. Res.,2015

5. Aurora A and B kinases as targets for cancer: will they be selective for tumors?;Matthews;Expert Rev. Anticancer. Ther.,2006

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3RT618I-driven cells;Blood Cells, Molecules, and Diseases;2024-01

2. The Aurora kinase inhibitor AT9283 inhibits Burkitt lymphoma growth by regulating Warburg effect;PeerJ;2023-12-11

3. Perspectives and mechanisms for targeting mitotic catastrophe in cancer treatment;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-09

4. Effect of Dasatinib on Genes Related to Mitotic Catastrophe Pathway in Chronic Myeloid Leukemia Cells;Anti-Cancer Agents in Medicinal Chemistry;2021-07-26

5. Targeting glioma cells by antineoplastic activity of reversine;Oncology Letters;2021-06-15